O

Ossur hf
OTC:OSSUY

Watchlist Manager
Ossur hf
OTC:OSSUY
Watchlist
Price: 4.265 USD Market Closed
Market Cap: $1.9B

Relative Value

There is not enough data to reliably calculate the relative value of OSSUY.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OSSUY Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

OSSUY Competitors Multiples
Ossur hf Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IS
Ossur hf
OTC:OSSUY
11.3B USD 2.2 31.2 16.4 24.4
US
Abbott Laboratories
NYSE:ABT
187.6B USD 4.2 28.8 16.5 22.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.7B USD 16.7 58.7 44.5 54.7
US
Stryker Corp
NYSE:SYK
128.8B USD 5.1 39.7 20.3 24.5
IE
Medtronic PLC
NYSE:MDT
111.8B USD 3.2 24.2 13.4 19.5
US
Boston Scientific Corp
NYSE:BSX
102.5B USD 5.1 35.4 20.8 27.9
DE
Siemens Healthineers AG
XETRA:SHL
43.9B EUR 1.9 20.7 11.5 16.2
US
Edwards Lifesciences Corp
NYSE:EW
47.5B USD 7.8 44.3 24.3 26.6
US
Becton Dickinson and Co
NYSE:BDX
45.4B USD 2.1 25.8 10.2 17.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.7B USD 10.6 43.2 30.7 34
US
Resmed Inc
NYSE:RMD
33.6B USD 6.2 22.6 15.9 17.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IS
O
Ossur hf
OTC:OSSUY
Average EV/EBITDA: 20.4
16.4
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
44.5
23%
1.9
US
Stryker Corp
NYSE:SYK
20.3
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.4
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.8
18%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
11.5
10%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.3
14%
1.7
US
Becton Dickinson and Co
NYSE:BDX
10.2
1%
10.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.7
11%
2.8
US
Resmed Inc
NYSE:RMD
15.9
11%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett